Regulus Therap (RGLS) Reports Q3 Loss of $15.98

Regulus Therap (NASDAQ: RGLS) reported Q3 EPS of ($15.98), versus ($11.68) reported last year. Revenue for the quarter came in at $2.8 million, versus $3.81 million reported last year.

For earnings history and earnings-related data on Regulus Therap (RGLS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Ardagh Metal Packaging S.A. Q2 2026 Results and Investor Call Notification
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance